Previous Close | 11.09 |
Open | 11.18 |
Bid | 11.29 x 1200 |
Ask | 12.00 x 2200 |
Day's Range | 11.15 - 11.81 |
52 Week Range | 4.81 - 17.21 |
Volume | |
Avg. Volume | 658,408 |
Market Cap | 547.926M |
Beta (5Y Monthly) | 0.40 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.61 |
Earnings Date | Feb 23, 2022 - Feb 28, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 18.67 |
The consensus price target hints at a 75.1% upside potential for Aerie (AERI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Here is how AmerisourceBergen (ABC) and Aerie Pharmaceuticals (AERI) have performed compared to their sector so far this year.
A Durham pharmaceutical company says it's making progress less than a year after significant changes at the executive level.